Menu Back toSession 7: Blockchain

Future of Evidence and Smart Health Conference

Leveraging RWE to advance healthcare decision-making.

Session 7: Blockchain

Session Chair(s)

Adama  Ibrahim, MBA

Adama Ibrahim, MBA

  • Director, Digital Solutions (Technology and Platforms)
  • Novartis Pharma AG, Switzerland
Aji  Barot

Aji Barot

  • Director, Global Commercial Development
  • Market Access Transformation, United Kingdom
Blockchain technology increases security and speeds up the exchange of information in a way that is cost-effective and more transparent. This technology has been increasingly used and considered in the healthcare sector as it can be applied to several aspects of the drug discovery and development lifecycle, namely data management, clinical trials, supply chain compliance, among many others. At this session, you will hear key stakeholders and users of Blockchain in Drug Development discussing challenges, risks and benefits.


Jeanne   Barnett

The Patient Advocate Perspective

Jeanne Barnett

  • Pathfinder for Patients and Caregivers, Teacher, CEO/Founder
  •, United States
Yusuf  Henriques, MPH

Diversity and Inclusion, Entrepreneur and Ex-Regulator Perspective

Yusuf Henriques, MPH

  • Founder and CEO
  • IndyGeneUS AI, United States
Sean  Manion, PhD

Blockchain Industry, Consortia and Consensys roadmap

Sean Manion, PhD

  • Chief Scientific Officer
  • ConsenSys Health, United States
Jim  Nasr, MBA

Blockchain Industry – Working with Hospitals during a Pandemic

Jim Nasr, MBA

  • Founder and Chief Executive Officer
  • ACOER and Ex-CDC, United States
Mathew  Rose, MD, MS, MSc

The Clinician Perspective

Mathew Rose, MD, MS, MSc

  • Founder and Chief Executive Officer
  • SAAVHA Inc., United States

Contact us

Trouble connecting on the day of the event?

Send Email
+41 61 225 51 51

Registration Questions?

Send Email
+41 61 225 51 51